Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seattle Children's Hospital
Nationwide Children's Hospital
Milton S. Hershey Medical Center
Nationwide Children's Hospital
Nationwide Children's Hospital
Children's Oncology Group
Children's Oncology Group
Shenzhen Geno-Immune Medical Institute
Nationwide Children's Hospital
Nationwide Children's Hospital
Nationwide Children's Hospital
Cellectar Biosciences, Inc.
Nationwide Children's Hospital
Ann & Robert H Lurie Children's Hospital of Chicago
Centre Oscar Lambret
Nationwide Children's Hospital
Washington University School of Medicine
University of Florida
Eli Lilly and Company
M.D. Anderson Cancer Center
Children's Oncology Group
Gustave Roussy, Cancer Campus, Grand Paris
Columbia University